Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
566 studies found for:    Open Studies | "Hormones"
Show Display Options
Rank Status Study
1 Recruiting Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Conditions: Hormone Receptor-Positive Breast;   Gynecologic;   Desmoid;   Hormone Receptor-Positive Neoplasms
Intervention: Drug: Z-Endoxifen
2 Recruiting Trial to Compare the Efficacy and Safety of NNC0195-0092 With Placebo and Norditropin® FlexPro® in Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: NNC0195-0092;   Drug: somatropin;   Drug: placebo
3 Unknown  Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth hormone
4 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
5 Recruiting Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth Hormone Replacement Therapy
6 Recruiting A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Condition: Growth Hormone-Deficiency
Interventions: Drug: TV-1106;   Drug: somatropin
7 Recruiting Anti-Mullerian Hormone Levels Before and After an Open Myomectomy
Condition: Anti-Mullerian Hormone
Intervention:
8 Unknown  Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (Nutropin)
9 Recruiting An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)
Condition: Adult Growth Hormone Deficiency
Intervention: Drug: Saizen® solution for injection (referred as Saizen®)
10 Recruiting Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: IV fluorine-18 labeled methylcholine before PET/CT
11 Unknown  Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: Fermented Wheat germ extract
12 Recruiting Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Conditions: Ductal Infiltrating Metastatic Breast Cancer;   Hormone-receptors Positive Breast Cancer
Intervention: Biological: Circulating tumor cells counting at baseline
13 Not yet recruiting Phase Ib Dose-escalation, Phase II Study of LEE011 and Letrozole for Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Condition: Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Interventions: Drug: LEE011;   Drug: Letrozole
14 Unknown  Effects of Lipids on Gastric Emptying, Satiety Hormones, and Appetite in Severe Overweight
Conditions: Effects of Lipids on Gastric Emptying;   Effects of Lipids on Satiety Hormones;   Effects of Lipids on Appetite
Intervention:
15 Unknown  Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
Condition: Hormone Deficiency
Interventions: Drug: Growth hormone treatment;   Drug: Testosterone treatment
16 Unknown  Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Conditions: Hormone-Sensitive Breast Cancer;   Breast Cancer
Interventions: Drug: Letrozole;   Drug: Bevacizumab
17 Recruiting Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic
Conditions: Estrogen Receptor Positive;   HER2/Neu Negative;   Hormone-Resistant Breast Cancer;   Male Breast Carcinoma;   Progesterone Receptor Positive;   Recurrent Breast Carcinoma;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: Exemestane;   Drug: Entinostat;   Drug: Goserelin Acetate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
18 Unknown  Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
Intervention:
19 Unknown  Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
20 Not yet recruiting Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Exemestane;   Drug: Everolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years